Duke University School of Medicine launched the Project Baseline study in North Carolina with the enrollment of Duke’s first participant in Kannapolis on June 29, 2017.
The study is the first initiative of Project Baseline, an ambitious effort to develop a well-defined “baseline” of human health and a rich data platform to help researchers better understand health and disease and the transitions between them.
Saying he wanted to contribute to a more profound understanding of why people get sick, a Landis, North Carolina resident in his 60s began the comprehensive study assessments at 10 a.m. on Thursday, June 29 at Duke’s clinical research office in Kannapolis. Surrounded by a team of researchers and technicians, the volunteer began a unique journey that will span at least four years and include study visits; donation of biological samples and health information; imaging and other clinical tests; and data collection by Verily Study Watch (an investigational device), a mobile app, and other sensors. Duke will enroll participants at two locations in North Carolina — in Kannapolis at the North Carolina Research Campus, and in Durham at Duke University Medical Center. Community advisory boards in both Kannapolis and Durham will provide crucial guidance to investigators to maintain the participant-centric mission of the study and ensure its success.
Anyone who is at least 18 years old, a resident of the United States, able to speak and read English or Spanish, and not severely allergic to nickel or metal jewelry may register online at projectbaseline.com and be considered for the study. Importantly, participants will be partners in the study through opportunities for feedback and interactions with the study leadership. A team of more than 40 people at Duke has worked for years with partners at Verily, Stanford Medicine, and Google to develop the Project Baseline study, which will enroll approximately 10,000 people overall and follow them for at least four years.
“The enrollment of Duke’s first participant was a tremendous milestone and testament to a collaboration between Duke, Verily, Stanford, Google, and, most importantly, our communities. We will bring together experts from academia, medicine, science, technology, engineering and design with participant partners to create a map of human health and potentially identify new warning signs for disease,” said L. Kristin Newby, MD, MHS, a Duke cardiologist and the principal investigator for the Duke site.
Duke enrolled the first participant—a woman in her 40s—at the Durham location on July 13. P. Kelly Marcom, MD, a Duke oncologist, is a co-principal investigator, and Paul T. Campbell, MD, a cardiologist in Concord, North Carolina, is the site investigator for the Kannapolis location. Only through the generous, ongoing participation of thousands of volunteers at Duke and elsewhere can the Project Baseline study hope to reach its ambitious goals. With the enrollment well underway, North Carolina’s role in the journey to map human health has begun.
To learn more, visit projectbaseline.com.